Relationship between plasma antioxidants and thyroid hormones in chronic obstructive pulmonary disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 10, 2012, Pages 623-628

  Mancini, A ^a   Corbo, G M ^a   Gaballo, A ^a   Raimondo, S ^a   Di Segni, C ^a   Gigliotti, P ^a   Silvestrini, A ^a   Valente, S ^a   Littarru, G P ^b   Pontecorvi, A ^a   Meucci, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

antioxidants; metabolic features; non thyroidal illness; oxidative stress; thyroid hormones

Indexed keywords

LIOTHYRONINE; METMYOGLOBIN; THYROID HORMONE; THYROTROPIN; THYROXINE; UBIDECARENONE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIOTHYRONINE BLOOD LEVEL; LUNG FUNCTION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; CHOLESTEROL; FEMALE; HUMANS; HYPOTHYROIDISM; ITALY; LUNG; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; UBIQUINONE;

EID: 84870295144     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1323808     Document Type: Article

References (58)

1. Michalaki M., Vagenakis A. G., Makri M. et al. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNF-alpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab: 2001; 86 4198 4205 (Pubitemid 32848536)
2. Umpierrez G. E. Euthyroid Sick Syndrome. South Med J: 2002; 95 506 513 (Pubitemid 34492336)
3. Chopra I. J. Clinical review 86: Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab: 1997; 82 329 334
4. McIver B., Gorman C. A. Euthyroid sick syndrome: an overview. Thyroid: 1997; 7 125 132 (Pubitemid 27132906)
5. Wong T. K., Hershman J. M. Changes in thyroid function in nonthyroidal illness. Trends Endocrinol Metab: 1992; 3 8 12
6. Laghi F., Adiguzel N., Tobin M. J. Endocrinological derangements in COPD. Eur Respir J: 2009; 34 975 996
7. Creutzberg E. C., Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J: 2003; 22 46 76s 80s (Pubitemid 37351739)
8. Dimopolou I., Ilias I., Mastorakos G. et al. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism Clin Exper: 2001; 50 1397 1401 (Pubitemid 34007407)
9. Okutan O., Kartaloglu Z., Onde M. E. et al. Pulmonary function tests and thyroid hormone concentrations in patients with chronic ostructive pulmonary disease. Med Princ Pract: 2004; 13 126 128 (Pubitemid 38456641)
10. Karadag F., Ozcan H., Karul A. B. et al. Correlates of non-thyroidal illness syndrome in chronic ostructive pulmonary disease. Respir Med: 2007; 101 1439 1446 (Pubitemid 46832231)
11. Bratel T., Wennlund A., Carlstrom K. Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD): Effects of long-term oxygen treatment. Respir Med: 2000; 94 1221 1228 (Pubitemid 32049250)
12. Couillard A., Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J: 2005; 26 703 719 (Pubitemid 41448671)
13. Ito K., Barnes P. J. COPD as a disease of accelerated lung aging. Chest: 2009; 135 173 180
14. Mancini A., De Marinis L., Calabrò F. et al. Physiopathological relevance of Coenzyme Q10 in thyroid disorders: CoQ10 concentrations in normal and diseased human thyroid tissue. In: Folkers K., Littarru G. P., Yamagami T. (eds.). Biomedical and clinical aspects of Coenzyme Q. Amsterdam Elsevier: 1991; 441 448
15. Mancini A., De Marinis L., Calabrò F. et al. Evaluation of metabolic status in amiodarone-induced thyroid disorders: plasma coenzyme Q10 determination. J Endocrinol Invest: 1989; 12 511 516 (Pubitemid 19249512)
16. Mancini A., Corbo G. M., Gaballo A. et al. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstrucive pulmonary disease. Biofactors: 2005; 25 201 204 (Pubitemid 44070850)
17. Prior R. L., Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Rad Biol Med: 1999; 27 1173 1181 (Pubitemid 30001476)
18. Bartoz G. Total antioxidant capacity. Adv Clin Chem: 2003; 37 219 292
19. 10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol: 2001; 21 585 593 (Pubitemid 32323393)
20. 10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem: 2003; 246 75 82 (Pubitemid 36798725)
21. 10 concentrations in coronary artery disease. Clin Biochem: 2004; 37 706 709 (Pubitemid 39078465)
22. 10 Ann Neurol: 1997; 41 160 165 (Pubitemid 27082096)
23. 10 in the Central nervous System and its Potential Usefulness in the Treatment of Neurodegenerative Diseases. Mol Aspects Med: 1997; 18 169 179
24. Mosca F., Fattorini D., Bompadre S. et al. Assay of coenzyme Q10 in plasma by a single dilution step. Anal Biochem: 2002; 305 49 54 (Pubitemid 34575824)
25. 10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors: 1999; 9 231 240 (Pubitemid 29289001)
26. Meucci E., Milardi D., Mordente A. et al. Total antioxidant capacity in patients with varicoceles. Fertil Steril: 2003; 79 (Suppl 3 ): 1577 1583 (Pubitemid 36687936)
27. Rice-Evans C., Miller N. J. Total antioxidant status in plasma and body fluids. Met Enzymol: 1994; 234 279 293
28. Scoscia E., Baglioni S., Eslami A. et al. Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol: 2004; 151 557 560 (Pubitemid 39562509)
29. Pechatnikov L. M. Significance of hypophyseo-thyroid disorders in chronic obstructive bronchitis. Klin Med (Mosk): 1989; 67 40 43
30. Gow S. M., Seth J., Beckett G. J. et al. Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive pulmonary disease. Thorax: 1987; 42 520 525 (Pubitemid 17097057)
31. Banks W. A., Cooper J. A. Hypoxia and hypercarbia of chronic lung disease: Minimal effects on anterior pituitary function. South Med J: 1990; 83 290 293 (Pubitemid 20108629)
32. De Groot L. J. "Non-thyroidal illness syndromeo" is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin: 2006; 22 57 86 (Pubitemid 43037110)
33. Brent G. A., Hershman J. M., Reed A. W. et al. Serum angiotensin converting enzyme in severe non thyroidal illness associated with low serum thyroxine concentration. Ann Int Med: 1986; 100 680 683 (Pubitemid 14143942)
34. Seppel T., Becker A., Lippert F. et al. Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations. J Clin Endocrinol Metab: 1996; 81 1663 1665 (Pubitemid 26118609)
35. Chopra I. J. An assessment of daily production and significance of thyroidal secretion of 3,3,5-triiodothyronine (reverse T3) in man. J Endocrinol Invest: 1976; 58 32 40
36. Hepner G. W., Chopra I. J. Serum thyroid hormone levels in patients with liver diseases. Arch Int Med: 1979; 139 1117 1120 (Pubitemid 10115919)
37. Utiger R. D. Decreased extrathyroidal triiodothyronine production in non thyroidal illness: benefit or harm? Am J Med: 1980; 69 807 810 (Pubitemid 11199848)
38. Van den Berghe G. H. The neuroendocrine stress response and modern intensive care: the concept revisited. Burns: 1999; 25 7 16 (Pubitemid 29092458)
39. Chopra I. J., Chopra U., Smith S. R. et al. Reciprocal changes in serum concentrations of 3,3,5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab: 1975; 41 1043 1049
40. Peeters R. P. Non thyroidal illness: to treat or not to treat? Ann Endocrinol: 2007; 68 224 228 (Pubitemid 47361081)
41. Arem R., Wiener G. J., Kaplan S. G. et al. Reduced issue thyroid hormone levels in fatal illness. Metabolism Clin Exp: 1993; 42 1102 1108 (Pubitemid 23292684)
42. Wehmann R. E., Gregerman R. I., Burns W. H. et al. Suppression of thyrotropin in the low-thyroxine state of severe non thyroidal illness. New Engl J Med: 1985; 312 546 552 (Pubitemid 15174150)
43. Van den Berghe G., De Zecher F., Baxter R. C. Neuroendocrinology of prolonged critical illness: Effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab: 1998; 83 309 319 (Pubitemid 28496498)
44. Belchetz P. E., Gredley G., Bird D. et al. Regulation of thyrotrophin secretion by negative feedback of triiodothyronine on the hypothalamus. J Endocrinol: 1978; 76 439 448 (Pubitemid 8285868)
45. Steinberg J. G., Faucher M., Guillot C. et al. Depressed fatigue-induced oxidative stress in chronic hypoxemic humans and rats. Respir Physiol Neurobiol: 2004; 141 179 189 (Pubitemid 38887255)
46. Faucher M., Steinberg J. G., Barbier D. et al. Influence of chronic hypoxiemia on peripheral muscle function and oxidative stress in humans. Clin Physiol Funct Imaging: 2004; 24 75 84 (Pubitemid 38489324)
47. Resch U., Helsel G., Tatzber F. et al. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med: 2002; 40 1132 1134 (Pubitemid 36024447)
48. Asayama K., Kato K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Rad Biol Med: 1990; 8 293 303
49. Dobrzynska M. M., Baumgartner A., Anderson D. Antioxidants modulate thyroid hormone- and noradrenaline-induced DNA damage in human sperm. Mutagenesis: 2004; 19 325 330 (Pubitemid 39028958)
50. Venditti P., Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci: 2006; 63 414 434
51. Hoch F. L. Lipids and thyroid hormones. Prog Lipid Res: 1988; 27 199 270
52. Ademoglu E., Gokkusu C., Yarman S. et al. The effect of methimazole on oxidants and antioxidants system in patients with hyperthyroidism. Pharmacol Res: 1998; 38 93 96 (Pubitemid 28349883)
53. Bianchi G., Solaroli E., Zaccheroni V. et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res: 1990; 31 620 624
54. Mancini A., Leone E., Festa R. et al. Effects of testosterone on antioxidant systems in male secondary hypogonadism. J Androl: 2008; 29 622 629
55. 10 levels in lipoprotein fractions in diabetics. Domyakukoka (Arteriosclerosis): 1982; 10 671 675
56. 14C-oleate by perfused livers from rats treated with triiodothyronine or propylthiouracil. Metabolism Clin Exper: 1981; 30 135 146 (Pubitemid 11154394)
57. Chait A., Bierman E. L., Albers J. J. Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab: 1979; 48 887 889 (Pubitemid 9172134)
58. 10 evaluation in pituitary-adrenal axis: preliminary data. Biofactors: 2005; 25 197 199 (Pubitemid 44070849)